Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection

Meitheal Pharmaceuticals Inc. has received FDA approval for and launched liraglutide injection (18 mg/3 mL), its generic equivalent for Victoza (Novo Nordisk), in the United States.